The IIT-Child Mind Institute study in Nature Neuroscience, an observational analysis of 20 mouse models plus 940 individuals with autism and over 1,000 controls drawn from the multi-site ABIDE repository, identifies two reproducible connectivity subtypes that together explain roughly one-quarter of cases. Hypoconnectivity aligned with synaptic gene enrichment while hyperconnectivity tracked immune-related pathways, offering the first direct cross-species mapping of molecular mechanisms to human fMRI signatures. Unlike earlier purely descriptive ABIDE analyses (Di Martino et al., Molecular Psychiatry 2014, n>1,000), this work anchors imaging phenotypes in specific cellular pathways, yet remains limited by its retrospective design, lack of randomization, and modest effect sizes on behavioral measures. What mainstream coverage overlooks is the translational gap: synaptic and immune targets already under investigation in separate trials (e.g., mGluR modulators for SHANK-related models) could now be stratified by subtype, but no longitudinal data yet confirm stability or treatment response. Conflicts of interest appear minimal, though ABIDE's aggregation across dozens of sites introduces scanner and protocol heterogeneity that the authors partially mitigated through reproducibility checks. The 25% coverage rate underscores that additional biological strata likely exist, demanding larger, prospective cohorts before any shift in diagnostic paradigms.